Mild microwave ablation combined with HSP90 and TGF‑β1 inhibitors enhances the therapeutic effect on osteosarcoma
Open Access
- 22 May 2020
- journal article
- research article
- Published by Spandidos Publications in Molecular Medicine Reports
- Vol. 22 (2) , 906-914
Abstract
Osteosarcoma is the most common malignant bone tumour and the second leading cause of cancer‑related death in children and adolescents. Microwave ablation has an excellent therapeutic effect on bone tumours by instantaneously increasing the temperature in the tumour; however, there is a risk of damaging the surrounding healthy tissues by exposure to a high temperature when the treatment power is too large. In the present study, two anti‑tumour reagents, a heat shock protein 90 (HSP90) inhibitor (PF‑04929113) and a transforming growth factor‑β1 (TGF‑β1) inhibitor (SB‑525334) were employed to enhance the therapeutic effect of mild‑power microwave ablation. It was revealed that microwaving to 48˚C combined with HSP90 and TGF‑β1 inhibitors significantly increased the apoptotic rate of VX2 cells. The same results were observed during in vivo experiments using New Zealand rabbits to model osteosarcoma. In addition, the results indicated that the expression of cytochrome c, caspase‑3 and caspase‑9 were upregulated in response to the treatment, which indicated that the mitochondrial apoptotic signalling pathway had been activated. These findings may provide a novel strategy for the development of microwave ablation in osteosarcoma treatment, which could effectively kill tumour cells without damaging the surrounding normal tissues.Keywords
This publication has 38 references indexed in Scilit:
- Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic OsteosarcomaJNCI: Journal of the National Cancer Institute, 2019
- The Hsp70–Hsp90 Chaperone Cascade in Protein FoldingTrends in Cell Biology, 2019
- HSP90 inhibitor geldanamycin reverts IL-13– and IL-17–induced airway goblet cell metaplasiaJournal of Clinical Investigation, 2019
- Hsp90 Mediates Membrane Deformation and Exosome ReleaseMolecular Cell, 2018
- Phase-II trials in osteosarcoma recurrences: A systematic review of past experienceEuropean Journal of Cancer, 2017
- Does Microwave Ablation of the Tumor Edge Allow for Joint-sparing Surgery in Patients With Osteosarcoma of the Proximal Tibia?Clinical Orthopaedics and Related Research, 2015
- Risk Factors for Metastatic Disease at Presentation with OsteosarcomaJournal of Bone and Joint Surgery, 2013
- Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and AngiogenesisJournal of Medicinal Chemistry, 2012
- Hsp90 Inhibitors Disrupt Mitochondrial Homeostasis in Cancer CellsChemistry & Biology, 2007
- Microwave hyperthermia treatment increases heat shock proteins in human skeletal muscleBritish Journal of Sports Medicine, 2007